| Jia, Weiping |
SUPER-2, NCT04998032: A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatment |
|
|
| Completed | 2/3 | 620 | RoW | supaglutide injection+metformin, placebo+metformin | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | Type2 Diabetes | 06/23 | 08/23 | | |
LIGHT, NCT06732960: A Study of the Efficacy and Safety of Efsubaglutide Alfa in Overweight or Obesity Patients |
|
|
| Active, not recruiting | 2 | 50 | RoW | Efsubaglutide Alfa, Supaglutide, Placebo | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd., Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Beijing Friendship Hospital, Jinan Central Hospital | Overweight or Obesity | 11/24 | 01/25 | | |
| Not yet recruiting | 2 | 273 | RoW | SHR-3167, Insulin glargine | Jiangsu HengRui Medicine Co., Ltd. | Type 2 Diabetes | 11/25 | 12/25 | | |
NCT03958838: Peer Support To Enhance The Shanghai Integration Model Of Diabetes Care: Dissemination To 12 Communities |
|
|
| Completed | N/A | 2160 | RoW | Peer Support Integrated with Primary Care | Shanghai 6th People's Hospital, University of North Carolina, Chapel Hill, Merck Foundation | Type2 Diabetes, PreDiabetes | 11/21 | 11/21 | | |
